TCRX
Tscan Therapeutics Inc
0.3335$
+0.8%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | +834.7% | +33.5% | +55.5% | -86.6% | +266.7% | |
| – | +117.9% | -83.8% | +54.4% | +1,616.0% | -95.3% | -30.2% | |
| – | – | – | +33.5% | +55.5% | -86.6% | +164.9% | |
| – | +117.9% | +118.5% | +33.1% | +47.4% | +21.8% | +6.3% | |
| – | +41.4% | +105.1% | +47.2% | +25.3% | +16.0% | +8.2% | |
| – | +41.4% | +772.0% | +36.4% | +42.8% | +20.2% | +4.1% | |
| – | – | – | – | – | – | – | |
| – | – | – | +7,250.0% | +219.6% | -2.8% | -24.2% | |
| – | – | – | – | – | – | – | |
| – | – | – | -113.4% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.